Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Anu Haveri, Anna Solastie, Nina Ekström, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 5, pp. 816-824
Open Access | Times Cited: 39
BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial
Juana Claus, Thijs ten Doesschate, Cheyenne Gumbs, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 19
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
Jennifer Serwanga, Violet Ankunda, Jackson Sembera, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
In-depth immunochemical characterization of the serum antibody response using a dual-titration microspot assay
Ágnes Melinda Kovács, Zoltán Hérincs, Krisztián Papp, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
Anna Solastie, Tuomo Nieminen, Nina Ekström, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 11
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
Nina Ekström, Tuija M. Leino, Aapo Juutinen, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 247-247
Open Access | Times Cited: 3
Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo-controlled study
Ruying Tang, Linyuan Wang, Jian-Jun Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020–2021
Timothée Dub, Anna Solastie, Lotta Hagberg, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Harmonization of Multiple SARS-CoV-2 Reference Materials Using the WHO IS (NIBSC 20/136): Results and Implications
William Windsor, Yannik Roell, Heidi R. Tucker, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 9
Portable high-throughput multimodal immunoassay platform for rapid on-site COVID-19 diagnostics
Yanke Shan, Bin Wang, Huachuan Huang, et al.
Analytica Chimica Acta (2022) Vol. 1238, pp. 340634-340634
Open Access | Times Cited: 9
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data
Juana Claus, Thijs ten Doesschate, Esther Taks, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 691-691
Open Access | Times Cited: 1
Approaches to evaluate the specific immune responses to SARS-CoV-2
Ana López-Gomez, Hector F. Pelaez-Prestel, Ignacio Juárez
Vaccine (2023) Vol. 41, Iss. 43, pp. 6434-6443
Open Access | Times Cited: 4
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
Nina Ekström, Anu Haveri, Anna Solastie, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 6
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University
Supawadee Makanut, Apirath Wangteeraprasert, Wittawat Jitpewngam, et al.
Vaccine (2023) Vol. 41, Iss. 29, pp. 4335-4340
Open Access | Times Cited: 2
Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents
Dorothée Obach, Anna Solastie, Oona Liedes, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 9
Open Access | Times Cited: 4
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study
Satendra Kumar, Liangliang Nan, Georgia Kalodimou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10898-10898
Open Access
Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19
Nina Ekström, Tuija Leino, Aapo Juutinen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Development of Serological Assays and Seroprevalence Studies of the New Coronavirus 2019 (COVID-19): Reports from Saudi Arabia
Thamir A. Alandijany, Arwa A. Faizo
Healthcare (2021) Vol. 9, Iss. 12, pp. 1730-1730
Open Access | Times Cited: 3
Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein
Hanora Van Ert, Dana Bohan, Kai J. Rogers, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Strong neutralizing antibody responses to SARS-CoV-2 variants following a single vaccine dose in subjects with previous SARS-CoV-2 infection
Nina Ekström, Anu Haveri, Anna Solastie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
Anna Solastie, Tuomo Nieminen, Nina Ekström, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Deep physico-chemical characterization of individual serum antibody responses against SARS-CoV-2 RBD using a dual titration microspot assay
Ágnes Kovács, Zoltán Hérincs, Krisztián Papp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top